Methods and compositions comprising tyrosine kinase inhibitor and triptolide for the treatment of cancer
Provided herein, inter alia, are methods, compositions and kits for treating cancer in a subject. The methods include administration of one or more tyrosine kinase inhibitors and triptolide or an analog thereof to the subject. The methods, compositions and kits are effective for preventing resistanc...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
13.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | Provided herein, inter alia, are methods, compositions and kits for treating cancer in a subject. The methods include administration of one or more tyrosine kinase inhibitors and triptolide or an analog thereof to the subject. The methods, compositions and kits are effective for preventing resistance and/or increasing sensitivity to tyrosine kinase inhibitors. |
---|---|
Bibliography: | Application Number: US202117225970 |